COVID-19: Vaccine Eligibility & Doses

COVID-19: Vaccine Eligibility & Doses 2nd dose vaccine 1,025,789,302 people with one dose administered of Covaxin or Oxford–AstraZeneca vaccine or Sputnik V · 952,033,158 people have been fully vaccinated with both 2nd dose vaccine If the 10 ug dose is the second dose, administer 3–8 weeks after the first dose; if it is the third dose, administer at least 8 weeks after the second dose

2nd dose vaccine In November 2017, a vaccine was approved by the FDA for use in the Heplisav-B is a two-dose vaccine approved for use in adults aged 18 and older

covaxin vaccine availability near me 1,025,789,302 people with one dose administered of Covaxin or Oxford–AstraZeneca vaccine or Sputnik V · 952,033,158 people have been fully vaccinated with both Blockwise 2nd Dose Due list of Covid 19 Vaccination